A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia

Clinical trial NCT00463385 · COMPLETED

Trial details

NCT number: NCT00463385
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelofibrosis With Myeloid Metaplasia Myeloid Metaplasia Myelofibrosis

Start date: 2007-04-01
Primary completion: 2009-05-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.